ehealth radio network
Episodes
Tuesday Feb 14, 2023
Tuesday Feb 14, 2023
Branislav Vajdic, PhD, and the Chief Executive Officer and Founder of HeartBeam, Inc. joins eHealth Radio and the Heart Health and Health News Channels. HeartBeam is the first 12-lead medical grade heart attack detection that's personal, portable, and easy-to-use.
Listen to interview with host Eric Michaels and guest Dr. Branislav Vajdic discuss the following:
Please tell us about your background and why you launched HeartBeam. We'd love to hear more about how this device is being used for the first time outside of a medical setting, and what makes it different from what's currently available.
According to the American Heart Association, more people die from heart attacks during the last week of December than at any other time of the year. How is HeartBeam positioned to slow this trend in terms of saving lives, trips to the hospitals, and how it helps people know if they are having a heart attack?
How will HeartBeam impact patients in remote areas and what does this mean for virtual medicine?
HeartBeam is being tested and in trials. Can you tell us a bit more? Where is HeartBeam currently being used? What has been the feedback from doctors and patients?
What's next for HeartBeam in 2023 and even in 2024?
Branislav Vajdic, PhD, Chief Executive Officer and Founder of HeartBeam, Inc, combines over 30 years of experience in technology development and senior management positions. Dr. Vajdic has been deeply involved with the development of HeartBeam’s technology to fit his vision for the Company.
Prior to HeartBeam from 2007 to 2010, Dr. Vajdic was CEO and Founder of NewCardio, a publicly traded company in the cardiovascular devices space. From 1984 to 2007, Dr. Vajdic was at Intel, where he held various senior management positions. At Intel, Dr. Vajdic was the designer of first Flash memory and two key inventions that enabled Flash as a product and led engineering groups responsible for Pentium 1 through Pentium 4 designs.
Dr. Vajdic was awarded two Intel Achievement Awards, the highest level of award for outstanding contributions to Intel. Dr. Vajdic is the author of numerous patents and publications in the fields of cardiovascular devices as well as chip design.
Website: https://www.heartbeam.com
Social Media Links: Twitter: https://twitter.com/HeartBeamInc LinkedIn: https://linkedin.com/company/heartbeam-inc
People also listened to this: Mental Health for Teens with Ken Baum
Monday Aug 22, 2022
Monday Aug 22, 2022
Bryant Lusk a military veteran, health advocate and author of his latest book "Heart Disease & Hypertension: Vitamin Therapy™ for a Healthy Heart" joins eHealth Radio and the Heart Health & Health News Channels.
Listen to host Eric Dye & guest Bryant Lusk discuss the following:
What prompted you to write about this subject?
What makes your book unique compared to others regarding heart disease or hypertension?
What are the three categories of risk factors for heart disease?
Can diet alone prevent heart disease and what are your feelings regarding food vs supplements?
How can one identify nutritional needs to protect against heart disease?
What nutritional supplements are most beneficial? Is there a danger in taking some supplements?
How does sleep affects heart disease?
What is the connection between the mind (emotions, stress, etc.) and the heart?
Bryant Lusk is a military veteran, author and health advocate. He grew up on the South Side of Chicago. Despite the challenges of gang violence and poverty, he became a successful Safety Inspector and Quality Control Specialist with the United States Government. Lusk spent four years in the United States Air Force, learning the true meaning of empowerment and pride. His desire to serve and protect others led him to begin writing his Share the Health book series, aiming to treat debilitating conditions. His latest book is: Heart Disease & Hypertension: Vitamin Therapy™ for a Healthy Heart (Koehlerbooks, May 2022).
Website: https://bryantlusk.com
Social Media Links: Linkedin: https://linkedin.com/in/bryantlusk Twitter: https://twitter.com/NotTheCans
Wednesday Jan 06, 2021
Wednesday Jan 06, 2021
Ken Londoner, the Chief Executive Officer, Founder and Director of BioSig Technologies that is working to develop and deliver the advanced signal processing solutions that will unlock the future of bio-electronic medicine, starting with the PURE EP™ System joins eHealth Radio and the Heart Health and Technology Channels.
Listen to interview with host Eric Michaels and guest Ken Londoner discuss the following:
Tell us a little bit about BioSig, the company’s mission and its efforts with in the medtech industry.
What does PURE EP help treat?
What types of current technologies are being used to treat AFib and how does your technology differ?
How is BioSig’s PURE EP reshaping the future of electrophysiology? How will this technology be used in hospitals, electrophysiology labs, and other institutions?
Tell us a little about BioSig’s subsidiary, ViralClear, and its potential antiviral candidate to treat COVID-19 patients.
BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals. The Company’s first product, PURE EP(tm) System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.
Website: www.biosig.com
Social Media Links: Facebook: facebook.com/biosigtechnologies Linkedin: linkedin.com/company/biosig-technologies-inc- Twitter: twitter.com/BioSig_Tech
Wednesday Dec 23, 2020
Wednesday Dec 23, 2020
Michael Feldschuh, the CEO of Daxor, an innovative medical instrumentation and biotechnology company focused on blood volume measurement joins eHealth Radio and the Health News and Technology Channels.
Listen to interview with host Eric Michaels and guest Michael Feldschuh discuss the following:
Can you tell me a bit about yourself and how you got interested in the medical technology field that led to your involvement with Daxor?
Let’s talk about BVA-100 and its benefits to physicians? How does BVA-100 differentiate from other similar technologies?
How does BVA-100 allow clinicians to provide better outcomes for their patients?
Are there any recent studies that validate BVA?
Please give us an overview of BVA-100 and how it improves outcomes for heart failure patients?
Daxor Corporation (NYSE: DXR) is an innovative medical instrumentation and biotechnology company focused on blood volume measurement. We developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. The BVA technology has the potential to improve hospital performance metrics in a broad range of surgical and medical conditions, including heart failure and critical care, by informing treatment strategies, resulting in significantly improved patient outcomes. Our mission is to partner with clinicians to incorporate BVA technology into standard clinical practice and improve the quality of life for patients.
Website: www.daxor.com
Social Media Links: Facebook: facebook.com/Daxorcorp Linkedin: linkedin.com/company/daxorcorporation Twitter: twitter.com/DaxorBVA
Saturday Sep 19, 2020
Saturday Sep 19, 2020
Dr. Waqaas Al-Siddiq, PhD the Founder and CEO of Biotricity a developer of advanced remote cardiac monitoring technology joins eHealth Radio and the Heart Health and Health News Channels.
Listen to interview with host Eric Michaels and guest Dr. Waqaas Al-Siddiq discuss the following:
What is Biotricity’s mission?
What is the problem you are solving?
How does Biotricity benefit doctor and their patients?
How do the Biotricity Bioflux and Biocentrix products work?
With the increase in stress and anxiety related to Covid-19, how can Biotricity reduce the problem?
Trying to maintain a healthy heart has become more difficult in the wake of COVID-19. While the pandemic has increased remote tele-health, there are glaring vulnerabilities due to a lack of real-time cardiac monitoring. Heart attacks are on the rise as a result of patients ignoring symptoms, staying home and not going to the hospital. COVID related stress has caused a surge in cardiac health issues. Additionally, some recovering COVID patients have since developed heart issues related to the virus. As a result, the need for real-time cardiac monitoring is more important than ever.
Dr. Waqaas Al-Siddiq has been at the forefront of remote monitoring solutions. He is the founder and CEO of Biotricity, developer of advanced remote cardiac monitoring technology. Waqaas believes COVID-19 has accelerated the ongoing shift in the health landscape from a reactive system to a prevention, personalized and more efficient tech-based system.
Waqaas, is a serial entrepreneur, a former investment advisor and an expert in wireless communication technology. Academically, he was distinguished for his various innovative designs in digital, analog, embedded, and micro-electro-mechanical products. His work was published in various conferences such as IEEE and the National Communication Council.
Waqaas has held several high-level design positions in IBM, AMD, and Intel. His achievements have been numerous in both the technical and academic world. Coupled with this, Waqaas has vast experience in leading various groups through his board experience and executive roles within start-ups, mid-sized companies, and non-profits.
Waqaas has a dual Bachelor’s degree in Computer Engineering and Economics, a Master’s in Computer Engineering from Rochester Institute of Technology, and a Master’s in Business Administration from Henley Business School. He also holds a Doctorate in Business with a specialty in Transformative Innovations and Billion Dollar Markets.
Website: https://www.biotricity.com
Social Media Links: Facebook: facebook.com/biotricity Linkedin: linkedin.com/company/biotricity-measuring-vitals Twitter: twitter.com/biotricity_inc
Monday Sep 23, 2019
Monday Sep 23, 2019
Dr. Rishin Shah, a Texas-based cardiologist who is triple-certified with board certifications in cardiovascular medicine, internal medicine, and interventional cardiology again joins eHealth Radio and the Heart Health & Health News Channels.
Listen to interview with host Eric Michaels and guest Dr. Rishin Shah discuss the following:
How many people die from heart related illnesses each year (17 million, more than cancer, HIV and malaria combined).
Why are we still seeing so many heart-related illnesses and death when there is so much medical information available?
What are the top three things a person can do to protect their heart health?
What if you have a family history of heart illness? Is there anything you can do to prevent an issue?
What's going on in the world of treatments and surgeries for heart illness patients? Are there breakthroughs or progress to report?
Dr. Rishin Shah, MD, has over 10 years of experience treating cardiovascular conditions and is a renowned cardiologist. He believes prevention is key to maintaining health and specializes in finding the least minimally invasive treatment options for his patients to get them back to optimal health.
At his practice, Prime Heart and Vascular, with locations in Plano, Frisco, and Allen, Texas, Dr. Shah is committed to serving his patients and the surrounding communities. He has expert knowledge in understanding the complications that arise at any age and provides state-of-the-art care so patients live longer, more fulfilling lives.
Cardiovascular conditions can be scary. Dr. Shah is committed to fostering a safe, welcoming, and compassionate environment for his patients at Prime Heart and Vascular, taking the necessary time to explain all aspects of procedures, conditions, and treatments. As a patient, you’re part of the family. And Dr. Shah’s core values provide care from the H.E.A.R.T.: hospitality; empathy and enthusiasm; attitude; respect; and teamwork. Dr. Shah received his medical degree from Saint Louis University School of Medicine and is board-certified in cardiovascular medicine, internal medicine, and interventional cardiology.
Website: www.primehv.com Blog: www.primehv.com/blog Reviews: www.primehv.com/testimonials Facebook: facebook.com/pages/Prime-Heart-and-Vascular
Friday Sep 20, 2019
Friday Sep 20, 2019
Dr. Evan Allen, a board-certified physician in obesity and owner at Total Care Family Practice in Las Vegas, Nevada joins eHealth Radio and the Nutrition & Weight Management Channels to talk about the dangers of saturated fats.
Listen to interview with host Eric Michaels & guest Dr. Evan Allen discuss the following:
How does the food industry purposefully mislead us?
What are some success stories you've seen with patients who cut out saturated fat in their diet?
If someone switches to a vegan diet, how quickly can they expect a recovery in their health?
Why write this book now?
What is one thing you want to tell other physicians with this book?
Tip: By minimizing the quantity of saturated fat in the diet, we can end heart disease and other ailments by practicing a lifestyle-first methodology, and reverting to medication and surgery as a last resort.
Dr. Evan Allen has been practicing medicine for a quarter century, and in that time, he’s opened two practices in Henderson, Nevada, and received board-certification from the American Board of Obesity Medicine. When Dr. Allen began to pay more attention to nutrition, the health of his patients improved. This discovery sent him on a search for a book like this one—a search that came up empty. With this book, Dr. Allen wants to give healthcare providers what he never had: a guide for talking to their patients about a healthy diet that’s low in saturated fat. Dr. Allen lives in Henderson with his son.
Website: www.totalcarefp.com
Thursday Jul 25, 2019
Thursday Jul 25, 2019
Dr. Rishin Shah, a Texas-based cardiologist who is triple-certified with board certifications in cardiovascular medicine, internal medicine, and interventional cardiology joins eHealth Radio and the Heart Health & Health News Channels.
Listen to interview with host Eric Michaels and guest Dr. Rishin Shah discuss the following:
Can you please define vascular health so people have an understanding of this key health area?
What are the key warning signs that indicate a possible vascular health issue?
Are some of the popular vein cosmetic treatments provide any medical benefit?
Why it is critically important to pay attention to our vascular health?
Are there side effects further down the road to worry about?
What are three things you can do starting today to maintain better vascular health?
Dr. Rishin Shah, MD, has over 10 years of experience treating cardiovascular conditions and is a renowned cardiologist. He believes prevention is key to maintaining health and specializes in finding the least minimally invasive treatment options for his patients to get them back to optimal health.
At his practice, Prime Heart and Vascular, with locations in Plano, Frisco, and Allen, Texas, Dr. Shah is committed to serving his patients and the surrounding communities. He has expert knowledge in understanding the complications that arise at any age and provides state-of-the-art care so patients live longer, more fulfilling lives.
Cardiovascular conditions can be scary. Dr. Shah is committed to fostering a safe, welcoming, and compassionate environment for his patients at Prime Heart and Vascular, taking the necessary time to explain all aspects of procedures, conditions, and treatments. As a patient, you’re part of the family. And Dr. Shah’s core values provide care from the H.E.A.R.T.: hospitality; empathy and enthusiasm; attitude; respect; and teamwork. Dr. Shah received his medical degree from Saint Louis University School of Medicine and is board-certified in cardiovascular medicine, internal medicine, and interventional cardiology.
Website: www.primehv.com Blog: www.primehv.com/blog Reviews: www.primehv.com/testimonials Facebook: facebook.com/pages/Prime-Heart-and-Vascular
Wednesday Aug 01, 2018
Wednesday Aug 01, 2018
Dr. Simon H. Stertzer, Professor Emeritus at Stanford University School of Medicine and Chairman of the Board at BioCardia, a clinical-stage biotech-regenerative medicine company that develops innovative therapeutics for the treatment of cardiovascular disease joins eHealth Radio and the Heart Health and Health News Channels.
Listen to interview with host Eric Michaels & guest Dr. Simon H. Stertzer discuss the following:
You’ve devoted your career to the advancement of cardiovascular intervention. Can you tell listeners a bit more about your background and why you decided to pursue a career in cardiovascular medicine?
How big of a problem is heart disease in the United States, and can you give me the profile of a typical patient with heart disease?
What is a the difference between heart attack, heart failure, and other kinds of heart disease?
How do we treat the different types of heart disease today?
How should we be screened for heart disease as adults?
Simon H. Stertzer, M.D. is Professor of Medicine, Emeritus, at Stanford University School of Medicine, and is currently Chairman of the Board of Directors at BioCardia®, Inc., a clinical-stage biotech-regenerative medicine company that develops innovative therapeutics for the treatment of cardiovascular disease. In 1964, Simon Stertzer performed the first selective coronary arteriogram in New York City. He pioneered the subspecialty of Interventional Cardiology by performing the first coronary balloon angioplasty in the United States, in 1978. He has performed more than 12,500 cardiac interventions and has worked alongside others to develop new technologies for the improvement of patient care. Dr. Stertzer has contributed to research and advancement in rotational atherectomy, cardiac stents, drug delivery stents, cardiac transplant molecular diagnostics, and most recently, transendocardial stem cell implantation in ischemic heart failure. His bibliography contains more than 140 peer-reviewed articles. Dr. Stertzer co-founded BioCardia in 1999, and was a founder and board member of Arterial Vascular Engineering, an angioplasty balloon and stent company acquired by Medtronic Inc..Simon Stertzer received his Doctor of Medicine degree from New York University, after a Bachelor of Arts degree in Humanities from Union College. He had previously earned a Certificat de Physiologie from University of Paris (Sorbonne). About BioCardia®, Inc.
BioCardia®, Inc. is helping lead the way to new treatments of heart failure using the direct injection of cells and agents into the heart muscle. BioCardia is a clinical-stage, regenerative biotechnology company that develops novel therapeutics to treat cardiovascular disease. The treatment modalities include a system of personalized screenings to determine which patients are most likely to benefit from intramyocardial injection of therapeutic agents.
Websites: www.biocardia.com | www.simonstertzer.com
Social Media Links: Linkedin: https://www.linkedin.com/in/simonstertzer Facebook: https://www.facebook.com/SimonStertzer
Tuesday Feb 13, 2018
Tuesday Feb 13, 2018
Dr. Anuj Tolia, a radiologist at Montclair Radiology, with 5 imaging facilities in New Jersey joins eHealth Radio and the Health News and Heart Health Channels to discuss the launching of a new model that is ground breaking. February is National Heart Month, and what better way to celebrate and safeguard our hearts than to offer free screening for first responders including police, fire and EMTs - which is exactly what Dr. Tolia and Montcliar Radiology is doing with "Docs and Cops".
Listen to interview with host Eric Michaels & guest Dr. Anuj Tolia discuss the following:
Can you describe in your own words how the Calcium Scoring works?
Should people with a family history of heart attacks, stroke and other conditions consider doing this scan?
Research shows stress is a killer - so does it make sense to recommend this to people who are in high stress careers, such as EMT staff, ER staff, Police, fire fighters, etc?
What about radiation - is this high or low - and what does that mean?
Do you need a prescription?
Cost is inexpensive, correct? I heard it was around $99.
Dr. Anuj J. Tolia received his BS at The Wharton School of Business and his Doctor of Medicine degree from New York University School of Medicine where he was elected to the Medical Honor Society, Alpha Omega Alpha. After completing an internship in Internal Medicine at Lenox Hill Hospital in New York, Dr. Tolia completed a residency in Diagnostic Radiology at New York University. Dr. Tolia received the Resident Research Scholarship Award presented by The Radiologic Society of North America.
Following his formal training at New York University Medical Center, Dr. Tolia completed a fellowship in Magnetic Resonance Imaging in Neuroradiology, Musculoskeletal Radiology and Body/Breast Imaging at Thomas Jefferson University Hospital in Philadelphia. Upon completing his fellowship, Dr. Tolia joined the staffs of Montclair Radiology and Chilton Memorial Hospital.
Dr. Tolia is a Diplomat of the American Board of Radiology and an active member of The American College of Radiology, The Radiological Society of North America, The American Roentgen Ray Society and The New York Roentgen Ray Society.
Website: www.montclairradiology.com
Facebook: https://www.facebook.com/MontclairRadiology